BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35522562)

  • 41. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
    O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
    PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric acute lymphoblastic leukemia-Conquering the CNS across the choroid plexus.
    März M; Meyer S; Erb U; Georgikou C; Horstmann MA; Hetjens S; Weiß C; Fallier-Becker P; Vandenhaute E; Ishikawa H; Schroten H; Dürken M; Karremann M
    Leuk Res; 2018 Aug; 71():47-54. PubMed ID: 30005184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse.
    Wu S; Gessner R; Taube T; Korte A; von Stackelberg A; Kirchner R; Henze G; Seeger K
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):216-20. PubMed ID: 16679918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of CXCR4 in the progression and therapy of acute leukaemia.
    Su L; Hu Z; Yang YG
    Cell Prolif; 2021 Jul; 54(7):e13076. PubMed ID: 34050566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.
    Zhang Y; Patel S; Abdelouahab H; Wittner M; Willekens C; Shen S; Betems A; Joulin V; Opolon P; Bawa O; Pasquier F; Ito M; Fujii N; Gonin P; Solary E; Vainchenker W; Coppo P; De Botton S; Louache F
    Cell Death Dis; 2012 Oct; 3(10):e396. PubMed ID: 23034331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
    Shen W; Bendall LJ; Gottlieb DJ; Bradstock KF
    Exp Hematol; 2001 Dec; 29(12):1439-47. PubMed ID: 11750103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The expression and clinical significance of stromal cell-derived factor-1 and CXCR4 in acute leukemia and malignant lymphoma].
    Zeng DF; Kong PY; Chen XH; Wei L; Chang C; Peng XG
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):522-4. PubMed ID: 16080846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL.
    Sison EA; Magoon D; Li L; Annesley CE; Romagnoli B; Douglas GJ; Tuffin G; Zimmermann J; Brown P
    Oncotarget; 2015 Oct; 6(31):30902-18. PubMed ID: 26360610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CXCL12/CXCR4 Mediates Orthodontic Root Resorption via Regulating the M1/M2 Ratio.
    Fang XY; Zhan YX; Zhou XM; Wu LN; Lin J; Yi YT; Jiang CM; Wang J; Liu J
    J Dent Res; 2022 May; 101(5):569-579. PubMed ID: 34847760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
    Juarez J; Bradstock KF; Gottlieb DJ; Bendall LJ
    Leukemia; 2003 Jul; 17(7):1294-300. PubMed ID: 12835717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.
    Domanska UM; Timmer-Bosscha H; Nagengast WB; Oude Munnink TH; Kruizinga RC; Ananias HJ; Kliphuis NM; Huls G; De Vries EG; de Jong IJ; Walenkamp AM
    Neoplasia; 2012 Aug; 14(8):709-18. PubMed ID: 22952424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
    Pan C; Liu P; Ma D; Zhang S; Ni M; Fang Q; Wang J
    Biomed Pharmacother; 2020 Oct; 130():110610. PubMed ID: 34321159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
    Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
    Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemia.
    Crazzolara R; Jöhrer K; Johnstone RW; Greil R; Kofler R; Meister B; Bernhard D
    Br J Haematol; 2002 Dec; 119(4):965-9. PubMed ID: 12472574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12.
    Melo RCC; Longhini AL; Bigarella CL; Baratti MO; Traina F; Favaro P; de Melo Campos P; Saad ST
    PLoS One; 2014; 9(1):e85926. PubMed ID: 24497931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
    Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Internal tandem duplication mutations in FLT3 gene augment chemotaxis to Cxcl12 protein by blocking the down-regulation of the Rho-associated kinase via the Cxcl12/Cxcr4 signaling axis.
    Onishi C; Mori-Kimachi S; Hirade T; Abe M; Taketani T; Suzumiya J; Sugimoto T; Yamaguchi S; Kapur R; Fukuda S
    J Biol Chem; 2014 Nov; 289(45):31053-65. PubMed ID: 25237195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.